PURR
NASDAQ · Biotechnology

Hyperliquid Strategies

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
$4.93
+0.26 (+5.57%)
As of Feb 8, 1:48 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +243.8% upside
Low Target $12.34
Average Target $16.95
High Target $26.10
Current Price $4.93
Current
$4.93
Target
$16.95
$12.34 $16.95 avg $26.10
Scenario Analysis
Bear Case
$12.34
150.3%
Low target
Base Case
$16.95
+243.8%
Avg target
Bull Case
$26.10
+429.4%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$5.78
-14.7% from high
52-Week Low
$3.01
+63.8% from low
Target vs 52W High
$16.95
+193.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%